Article info
Short report
Melphalan as a treatment for BRCA-related ovarian carcinoma: can you teach an old drug new tricks?
- Correspondence to Dr William D Foulkes, Program in Cancer Genetics, Gerald Bronfman Centre for Clinical Research in Oncology, 546 Pine Avenue West, McGill University, Montreal, Quebec H2W 1S6, Canada; william.foulkes{at}mcgill.ca
Citation
Melphalan as a treatment for BRCA-related ovarian carcinoma: can you teach an old drug new tricks?
Publication history
- Accepted January 31, 2011
- First published March 4, 2011.
Online issue publication
August 10, 2020
Article Versions
- Previous version (10 August 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.